XKON/140610 (XKON/140610)

Korea New Exchange: XKON/140610 · KRW

₩8,320

-10.00 (-0.1%)· Recorded snapshot

Market cap	119.6B
Revenue (ttm)	537.5M
Net income (ttm)	-5.4B
EPS (ttm)	-₩644
Shares out	14.4M
Volume	2,230
Beta	0.70

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 537.5M
Net income (ttm): -5.4B
EPS (ttm): -₩644
Market cap: 119.6B

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROE-59.1

P25 n/aP50 n/aP75 n/a

ROIC-35.3

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All XKON/140610 indicators

Market & fundamental data

Available fields

146

Groups with data

Currency

KRW

Showing 146 of 146 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	KRW
Country	South Korea
Country code	KR
Exchange	Korea New Exchange
Financial currency	KRW
First seen	2026-05-10
Fiscal year end	December
Founded	2001
Industry	Biological Products, Except Diagnostic Substances
Is primary listing	Yes
ISIN number	KR7140610007
Last refreshed	2026-10-28
Market cap	KRW 119.6B
Price	KRW 8,320.00
Price currency	KRW
SIC code	2836
Stock price date	2026-10-27
Symbol	xkon/140610
Website	https://ensolbio.co.kr

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	-7.74%
FCF yield	-4.01%
P/B ratio	18.22x
P/S ratio	222.55x
Price / tangible book value	18.59x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross margin	28.48%
Operating margin	-961.08%
Pretax margin	-1,005.43%
ROA	-31.45%
ROCE	-70.71%
ROE	-59.14%
ROIC	-35.28%
SBC / revenue	47.27%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Revenue growth	208.94%

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	KRW -142.8M
Depreciation and amortization	KRW 398.4M
EBIT	KRW -5.2B
EBITDA	KRW -4.8B
EPS	KRW -644.00
FCF per share	KRW -333.60
Financing cash flow	KRW 30M
Free cash flow	KRW -4.8B
Free cash flow minus SBC	KRW -5.1B
Gross profit	KRW 153M
Investing cash flow	KRW 2.4B
Net borrowing	KRW 30M
Net cash flow	KRW -2.2B
Net income	KRW -5.4B
Operating cash flow minus SBC	KRW -4.9B
Operating income	KRW -5.2B
Revenue	KRW 537.5M
Stock-based compensation	KRW 254.1M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	-7.18
Book value per share	KRW 782.26
Debt / equity	0
Interest coverage	-2,544.54
Long-term assets	KRW 4.8B
Long-term liabilities	KRW 741M
Net cash (debt)	KRW 2.6B
Net cash / market cap	2.17%
Net debt / equity	-0.39
Piotroski F-Score	1
Property, plant and equipment	KRW 4.2B
Shareholders' equity	KRW 6.6B
Tangible book value	KRW 6.4B
Tangible book value per share	KRW 767.00
Total assets	KRW 7.6B
Total cash	KRW 2.6B
Total debt	KRW 30M
Total liabilities	KRW 1.1B
WACC	8.11%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.05
Current assets	KRW 2.9B
Current liabilities	KRW 316.4M
Current ratio	9.01
Net working capital	KRW -58.4M
Quick ratio	8.46
Working capital	KRW 2.5B

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	KRW 11,843.73
1D price change	-0.12%
1M price change	-17.87%
1M total return	-17.87%
1W price change	-8.17%
1W total return	-8.17%
1Y price change	-43.4%
1Y return CAGR	-43.42%
1Y total return	-43.4%
20-day SMA	KRW 9,226.00
200-day SMA	KRW 12,310.60
3M price change	-30.14%
3M total return	-30.14%
3Y price change	-5.45%
3Y return CAGR	-1.85%
3Y total return	-5.45%
50-day SMA	KRW 9,868.80
50-day SMA vs 200-day SMA	50under200
52-week high	KRW 17,900.00
52-week high date	2026-01-27
52-week low	KRW 7,750.00
52-week low date	2026-10-26
5Y price change	-46.5%
5Y return CAGR	-11.76%
5Y total return	-46.5%
6M price change	-41.41%
6M total return	-41.41%
All-time high	KRW 38,800.00
All-time high date	2025-07-01
All-time low	KRW 2,800.00
All-time low date	2024-03-22
Average true range (ATR)	KRW 679.04
Average volume	6.2K
Beta (1Y)	0.44
Beta (2Y)	0.27
Beta (5Y)	0.7
Change from 52-week high	-53.52%
Change from 52-week low	7.36%
Change from all-time high	-78.56%
Change from all-time low	197.14%
Change from open	5.05%
Day's gap	-4.92%
Dollar volume	KRW 18.6M
High price	KRW 8,350.00
Low price	KRW 7,920.00
Monthly RSI	39.7
Open price	KRW 7,920.00
Position in 52-week range	93.02%
Previous close	KRW 8,330.00
Price vs 150-day SMA	-29.75%
Price vs 20-day SMA	-9.82%
Price vs 200-day SMA	-32.42%
Price vs 50-day SMA	-15.69%
Relative volume	0.36
RSI	34.57
Sharpe ratio	-1.09
Sharpe ratio (3Y)	0.15
Sharpe ratio (5Y)	0.01
Sortino ratio	-1.5
Sortino ratio (3Y)	0.31
Sortino ratio (5Y)	0.11
Volume	2.2K
Weekly RSI	30.24
YTD price change	-36.63%
YTD total return	-36.63%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	9.4M
Shares held by insiders	30.64%
Shares held by institutions	2.39%
Shares outstanding	14.4M

Deeper analysis on XKON/140610

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this XKON/140610 report

Is a complete XKON/140610 research report available?

No complete published report is available for xkon/140610 (XKON/140610) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

XKON/140610 (XKON/140610)

Price

Financial snapshot

Fair-value bridge

Latest news · XKON/140610

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All XKON/140610 indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Performance and technicals

Ownership and float

Deeper analysis on XKON/140610

Frequently asked questions